CEACAM5 and cancer: Previously established prognostic markers for cancers at high risk of recurrence include local tumour extent, regional lymph node metastasis, blood or lymphatic vessel invasion, residual tumour after curative surgery, and preoperative elevation of carcinoembryonic antigen (CEA) (Compton et al, 2000).